Lanean...
Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 CAR T-cell therapy
Radiotherapy is potentially an important salvage strategy post-chimeric antigen receptor T-cell therapy (CART) but limited data exist. We reviewed 14 patients treated with salvage radiation post-CART progression (SRT). Most received SRT for first post-CART relapse (71%) to sites previously PET-avid...
Gorde:
| Argitaratua izan da: | Br J Haematol |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7329607/ https://ncbi.nlm.nih.gov/pubmed/32135029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16541 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|